Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia
Public ClinicalTrials.gov record NCT04803305. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 6-WEEK, RANDOMIZED, DOUBLE-BLIND, SPONSOR-OPEN STUDY TO ASSESS THE EFFECT OF REPEATED SUBCUTANEOUS ADMINISTRATION OF PF-06946860 ON APPETITE IN PARTICIPANTS WITH ADVANCED CANCER AND ANOREXIA, FOLLOWED BY AN 18-WEEK OPEN-LABEL TREATMENT PERIOD
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Study to compare the effects of the investigational new drug (PF-06946860) and a placebo on appetite and to find out how participants with advanced cancer and anorexia feel after receiving repeated subcutaneous (SC-injected under the skin) doses.
Study identification
- NCT ID
- NCT04803305
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 18 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 11, 2021 (Actual)
- Primary completion
- Apr 14, 2022 (Actual)
- Completion
- Aug 9, 2022 (Actual)
- Last update posted
- Jan 12, 2024
2021 – 2022
United States locations
- U.S. sites
- 32
- U.S. states
- 8
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| CARTI Cancer Center | Little Rock | Arkansas | 72205 | — |
| Tower Hematology Oncology Medical Group (THO) | Beverly Hills | California | 90211 | — |
| Ventura County Hematology- Oncology Specialists | Camarillo | California | 93010 | — |
| Cedars- Sinai Medical Center | Los Angeles | California | 90048 | — |
| Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute | Los Angeles | California | 90048 | — |
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | — |
| Ventura County Hematology Oncology Specialists | Oxnard | California | 93030 | — |
| Providence Medical Foundation | Santa Rosa | California | 95403 | — |
| Ventura County Hematology-Oncology Specialists | Ventura | California | 93003 | — |
| Lutheran Medical Center | Wheat Ridge | Colorado | 80033 | — |
| Fort Wayne Medical Oncology and Hematology, Inc. | Fort Wayne | Indiana | 46804 | — |
| Bozeman Health Cancer Center | Bozeman | Montana | 59715 | — |
| Bozeman Health Deaconess Hospital d/b/a Bozeman Health Clinical Research | Bozeman | Montana | 59715 | — |
| Bozeman Health Deaconess Hospital | Bozeman | Montana | 59715 | — |
| Mary Crowley Cancer Research | Dallas | Texas | 75230 | — |
| The University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| US Oncology Investigational Product Center (IPC) | Irving | Texas | 75063 | — |
| Texas Oncology - Longview Cancer Center | Longview | Texas | 75601 | — |
| Texas Oncology-Paris | Paris | Texas | 75460 | — |
| Texas Oncology- Tyler | Tyler | Texas | 75702 | — |
| Cancer Center IDS Pharmacy | Charlottesville | Virginia | 22903 | — |
| University of Virginia Cancer Center | Charlottesville | Virginia | 22903 | — |
| UVA Health System; Attention: GI Team | Charlottesville | Virginia | 22903 | — |
| University of Virginia Health System | Charlottesville | Virginia | 22908 | — |
| MultiCare Regional Cancer Center - Auburn | Auburn | Washington | 98001 | — |
| MultiCare Regional Cancer Center - Gig Harbor Medical Park | Gig Harbor | Washington | 98335 | — |
| Moses Lake Clinic | Moses Lake | Washington | 98837 | — |
| MultiCare Regional Cancer Center - Puyallup | Puyallup | Washington | 98372 | — |
| Medical Oncology Associates, PS (dba Summit Cancer Centers) | Spokane Valley | Washington | 99216 | — |
| MultiCare Institute for Research & Innovation | Tacoma | Washington | 98405 | — |
| MultiCare Regional Cancer Center - Tacoma | Tacoma | Washington | 98405 | — |
| Wenatchee Valley Hospital | Wenatchee | Washington | 98801 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04803305, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 12, 2024 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04803305 live on ClinicalTrials.gov.